We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
-14.58%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.56T
AUM Growth
-$670B
Cap. Flow
+$37.7B
Cap. Flow %
1.06%
Top 10 Hldgs %
19.88%
Holding
4,705
New
80
Increased
2,623
Reduced
1,419
Closed
84

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$2.89B
2
TSLA icon
Tesla
TSLA
+$2.51B
3
MSFT icon
Microsoft
MSFT
+$1.77B
4
VICI icon
VICI Properties
VICI
+$1.23B
5
AMZN icon
Amazon
AMZN
+$1.22B

Sector Composition

Rank Sector Weight
1 Technology 22.63%
2 Healthcare 14.28%
3 Financials 13.35%
4 Consumer Discretionary 9.84%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOSL icon
2126
Alpha and Omega Semiconductor
AOSL
$1.08B
$58.1M ﹤0.01%
1,743,847
-214,895
-11% -$8.8M
BF.A icon
2127
Brown-Forman Class A
BF.A
$13.3B
$58M ﹤0.01%
857,909
+64,460
+8% +$4.09M
ALEC icon
2128
Alector
ALEC
$199M
$58M ﹤0.01%
5,708,696
+264,773
+5% +$2.64M
DCPH
2129
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$57.8M ﹤0.01%
4,392,946
+798,434
+22% +$8.81M
FLNA
2130
Filana Therapeutics
FLNA
$48.1M
$57.6M ﹤0.01%
2,047,712
+72,983
+4% +$1.84M
RLX icon
2131
RLX Technology
RLX
$2.46B
$57.6M ﹤0.01%
27,028,445
-6,041
-0% -$12.1K
ISEE
2132
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$57.5M ﹤0.01%
5,981,916
+203,187
+4% +$2.55M
CSIQ icon
2133
Canadian Solar
CSIQ
$1.08B
$57.5M ﹤0.01%
1,846,907
+143,087
+8% +$4.4M
CCRN
2134
DELISTED
Cross Country Healthcare
CCRN
$57.5M ﹤0.01%
2,760,728
+126,265
+5% +$2.37M
XPEL icon
2135
XPEL
XPEL
$1.38B
$57.4M ﹤0.01%
1,248,855
-41,452
-3% -$1.96M
GDEN
2136
DELISTED
Golden Entertainment
GDEN
$57.3M ﹤0.01%
1,448,373
+126,179
+10% +$5.94M
MYE icon
2137
Myers Industries
MYE
$1.29B
$57M ﹤0.01%
2,508,008
+50,548
+2% +$1.15M
RXRX icon
2138
Recursion Pharmaceuticals
RXRX
$1.73B
$56.9M ﹤0.01%
6,987,467
+376,090
+6% +$2.52M
ATRA icon
2139
Atara Biotherapeutics
ATRA
$76.1M
$56.9M ﹤0.01%
291,923
+15,420
+6% +$2.52M
KYMR icon
2140
Kymera Therapeutics
KYMR
$8.94B
$56.6M ﹤0.01%
2,874,724
+36,999
+1% +$864K
OR icon
2141
OR Royalties Inc
OR
$6.2B
$56.6M ﹤0.01%
5,601,158
-469,991
-8% -$5.64M
AAN
2142
DELISTED
The Aaron's Company Inc
AAN
$56.4M ﹤0.01%
3,875,424
-101,336
-3% -$1.93M
CIO
2143
DELISTED
City Office REIT
CIO
$56.1M ﹤0.01%
4,330,417
-102,886
-2% -$1.46M
ICHR icon
2144
Ichor Holdings
ICHR
$2.56B
$56M ﹤0.01%
2,153,682
-213,870
-9% -$6.2M
ATNI icon
2145
ATN International
ATNI
$492M
$55.8M ﹤0.01%
1,190,407
+78,301
+7% +$3.32M
RDNT icon
2146
RadNet
RDNT
$5.69B
$55.8M ﹤0.01%
3,231,531
-32,742
-1% -$637K
PARR icon
2147
Par Pacific Holdings
PARR
$3.32B
$55.7M ﹤0.01%
3,571,276
-48,056
-1% -$757K
TGTX icon
2148
TG Therapeutics
TGTX
$7.62B
$55.3M ﹤0.01%
13,020,832
+889,869
+7% +$5.56M
IONQ icon
2149
IonQ
IONQ
$16.6B
$55.2M ﹤0.01%
12,597,710
+8,831,677
+235% +$62.5M
JBI icon
2150
Janus International
JBI
$757M
$55.1M ﹤0.01%
6,096,856
+490,987
+9% +$4.77M

Similar funds

Vanguard Group's Q2 2022 Portfolio in Review

As of Q2 2022, Vanguard Group held 4,705 positions worth $3.56T, down 16% from $4.23T the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 3.5%. Vanguard Group opened 80 new positions and exited 84, leaving the 4,705-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Vanguard Group's largest Q2 2022 buy was ESAB: 5,042,669 shares worth $221M.
  • Vanguard Group added most to Warner Bros in Q2 2022, an estimated $2.89B increase.
  • Vanguard Group's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.57B.
  • Vanguard Group fully exited Cerner Corp in Q2 2022, selling an estimated $3.01B.
  • Vanguard Group's ten largest holdings make up 20% of its $3.56T portfolio in Q2 2022.
  • Vanguard Group opened 80 new positions and closed 84 in Q2 2022.
  • Vanguard Group's portfolio value fell 16% quarter-over-quarter to $3.56T.

Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.